ESPR vs. MPWR
ESPR (Esperion Therapeutics, Inc.) and MPWR (Monolithic Power Systems, Inc.) are both stocks. ESPR operates in Biotechnology (Healthcare), while MPWR operates in Semiconductors (Technology). Over the past 10 years, ESPR returned -14.95%/yr vs 37.94%/yr for MPWR. At a 0.24 correlation, their price movements are largely independent.
Performance
ESPR vs. MPWR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ESPR achieves a -14.86% return, which is significantly lower than MPWR's 74.38% return. Over the past 10 years, ESPR has underperformed MPWR with an annualized return of -14.95%, while MPWR has yielded a comparatively higher 37.94% annualized return.
ESPR
- 1D
- 0.00%
- 1M
- 0.96%
- YTD
- -14.86%
- 6M
- -18.18%
- 1Y
- 162.50%
- 3Y*
- 35.36%
- 5Y*
- -34.62%
- 10Y*
- -14.95%
MPWR
- 1D
- -0.77%
- 1M
- -4.43%
- YTD
- 74.38%
- 6M
- 67.26%
- 1Y
- 121.18%
- 3Y*
- 44.43%
- 5Y*
- 36.35%
- 10Y*
- 37.94%
ESPR vs. MPWR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ESPR Esperion Therapeutics, Inc. | -14.86% | 68.18% | -26.42% | -52.01% | 24.60% | -80.77% | -56.40% | 29.63% | -30.13% | 425.88% |
MPWR Monolithic Power Systems, Inc. | 74.38% | 54.45% | -5.55% | 79.78% | -27.78% | 35.49% | 107.49% | 54.80% | 4.49% | 38.23% |
Correlation
The correlation between ESPR and MPWR is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Jun 26, 2013 | 0.24 |
The correlation between ESPR and MPWR shifts across timeframes, from 0.13 (1 year) to 0.24 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ESPR:
$791.76M
MPWR:
$77.67B
ESPR:
-$0.03
MPWR:
$13.89
ESPR:
1.75
MPWR:
25.93
ESPR:
$418.24M
MPWR:
$2.96B
ESPR:
$226.32M
MPWR:
$1.63B
ESPR:
$77.18M
MPWR:
$861.78M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ESPR vs. MPWR — Risk / Return Rank
ESPR
MPWR
ESPR vs. MPWR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Esperion Therapeutics, Inc. (ESPR) and Monolithic Power Systems, Inc. (MPWR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ESPR | MPWR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.75 | ||
| Sortino ratioReturn per unit of downside risk | -0.14 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 1.37 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 3.07 | 5.43 | -2.35 |
| Martin ratioReturn relative to average drawdown | 7.68 | 14.45 | -6.77 |
Loading charts...
Drawdowns
ESPR vs. MPWR - Drawdown Comparison
The maximum ESPR drawdown since its inception was -99.37%, which is greater than MPWR's maximum drawdown of -72.27%. Use the drawdown chart below to compare losses from any high point for ESPR and MPWR.
Loading charts...
Drawdown Indicators
| ESPR | MPWR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.37% | -72.27% | -27.10% |
Max Drawdown (1Y)Largest decline over 1 year | -53.19% | -22.45% | -30.74% |
Max Drawdown (3Y)Largest decline over 3 years | -80.94% | -51.65% | -29.29% |
Max Drawdown (5Y)Largest decline over 5 years | -97.16% | -51.65% | -45.51% |
Max Drawdown (10Y)Largest decline over 10 years | -99.10% | -51.65% | -47.45% |
Current DrawdownCurrent decline from peak | -97.27% | -6.66% | -90.61% |
Average DrawdownAverage peak-to-trough decline | -69.99% | -17.71% | -52.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.30% | 8.44% | +12.86% |
Volatility
ESPR vs. MPWR - Volatility Comparison
The current volatility for Esperion Therapeutics, Inc. (ESPR) is 1.06%, while Monolithic Power Systems, Inc. (MPWR) has a volatility of 20.33%. This indicates that ESPR experiences smaller price fluctuations and is considered to be less risky than MPWR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ESPR | MPWR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.06% | 20.33% | -19.27% |
Volatility (6M)Calculated over the trailing 6-month period | 61.44% | 37.42% | +24.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 92.66% | 48.53% | +44.13% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.79% | 53.53% | +38.26% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.61% | 47.23% | +37.38% |
Dividends
ESPR vs. MPWR - Dividend Comparison
ESPR has not paid dividends to shareholders, while MPWR's dividend yield for the trailing twelve months is around 0.42%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ESPR Esperion Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
MPWR Monolithic Power Systems, Inc. | 0.42% | 0.69% | 0.85% | 0.63% | 0.85% | 0.49% | 0.55% | 0.90% | 1.03% | 0.71% | 0.98% | 1.26% |
Financials
ESPR vs. MPWR - Financials Comparison
This section allows you to compare key financial metrics between Esperion Therapeutics, Inc. and Monolithic Power Systems, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ESPR vs. MPWR - Profitability Comparison
ESPR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Esperion Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 80.10M. Therefore, the gross margin over that period was 0.0%.
MPWR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Monolithic Power Systems, Inc. reported a gross profit of 445.07M and revenue of 804.19M. Therefore, the gross margin over that period was 55.3%.
ESPR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Esperion Therapeutics, Inc. reported an operating income of -6.58M and revenue of 80.10M, resulting in an operating margin of -8.2%.
MPWR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Monolithic Power Systems, Inc. reported an operating income of 241.15M and revenue of 804.19M, resulting in an operating margin of 30.0%.
ESPR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Esperion Therapeutics, Inc. reported a net income of -25.20M and revenue of 80.10M, resulting in a net margin of -31.5%.
MPWR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Monolithic Power Systems, Inc. reported a net income of 193.23M and revenue of 804.19M, resulting in a net margin of 24.0%.
Frequently Asked Questions
ESPR and MPWR have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MPWR has higher volatility (20.33%) compared to ESPR (1.06%). In terms of maximum drawdown, ESPR dropped -99.37% vs MPWR's -72.27%.
MPWR currently has the higher Sharpe Ratio (2.51 vs 1.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ESPR and MPWR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer